Timing flexibility of oral NEPA, netupitant-palonosetron combination, administration for the prevention of chemotherapy-induced nausea and vomiting (CINV)

PURPOSE: The administration timing of antiemetic and chemotherapeutic regimens is often determined by regulatory indications, based on registration studies. Oral NEPA, fixed combination of the neurokinin-1 receptor antagonist (NK(1)RA) netupitant and the 5-hydroxytryptamine-3 RA (5-HT(3)RA) palonose...

Descripción completa

Detalles Bibliográficos
Autores principales: Baron-Hay, Sally, Aapro, Matti, Bernareggi, Alberto, Schwartzberg, Lee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394711/
https://www.ncbi.nlm.nih.gov/pubmed/30685793
http://dx.doi.org/10.1007/s00520-019-4640-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394711/
https://www.ncbi.nlm.nih.gov/pubmed/30685793
http://dx.doi.org/10.1007/s00520-019-4640-8

Ejemplares similares